CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein
Intest Res. 2022;20(1):72-77.   Published online February 3, 2021
DOI: https://doi.org/10.5217/ir.2020.00117

Excel Download

Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
Intestinal Research. 2022;20(1):72-77   Crossref logo
Link1 Link2 Link3

P296 vedolizumab Does Not Increase Risk of Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease Using vedolizumab: a Retrospective Cohort Study
Journal of Crohn's and Colitis. 2022;16(Supplement_1):i326-i326   Crossref logo
Link1 Link2

Sa1806 - Vedoizumab Does not Increase Perioperative Surgical Complications in Patients with Inflammatory Bowel Disease
Gastroenterology. 2018;154(6):S-402   Crossref logo
Link1 Link2

Corrigendum to Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study
Inflammatory Bowel Diseases. 2018;24(12):2657-2657   Crossref logo
Link1

Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
Intestinal Research. 2022;20(1):1-2   Crossref logo
Link1 Link2 Link3

Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review
The Surgeon. 2021;19(5):e153-e167   Crossref logo
Link1 Link2

P885 Does long term corticosteroid use increase the risk of femur fracture in Inflammatory Bowel Disease patients? : A nationwide population-based cohort study
Journal of Crohn's and Colitis. 2023;17(Supplement_1):i1003-i1004   Crossref logo
Link1 Link2

DOP49 Effectiveness and safety of vedolizumab in a matched cohort of elderly and young Inflammatory Bowel Disease patients - LIVE Study-Group
Journal of Crohn's and Colitis. 2021;15(Supplement_1):S085-S085   Crossref logo
Link1 Link2

Su1864 VEDOLIZUMAB IS SAFE IN VETERAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE OVER AGE 65: RETROSPECTIVE COHORT
Gastroenterology. 2020;158(6):S-680   Crossref logo
Link1 Link2

Fr524 EFFICACY OF VEDOLIZUMAB IN A NATIONWIDE COHORT OF ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS
Gastroenterology. 2021;160(6):S-346   Crossref logo
Link1 Link2